XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Feb. 27, 2022
Nov. 28, 2021
Current Assets:    
Cash and cash equivalents $ 678,306 $ 810,266
Short-term investments 98,843 91,550
Trade receivables, net 648,233 707,625
Inventories 1,006,180 897,950
Other current assets 181,468 202,510
Total current assets 2,613,030 2,709,901
Property, plant and equipment, net 491,831 502,562
Goodwill 377,577 386,880
Other intangible assets, net 290,270 291,332
Deferred tax assets, net 553,160 573,114
Operating lease right-of-use assets, net 1,085,780 1,103,705
Other non-current assets 340,103 332,575
Total assets 5,751,751 5,900,069
Current Liabilities:    
Accounts payable 562,972 524,838
Accrued salaries, wages and employee benefits 188,829 274,700
Accrued sales returns and allowances 192,464 209,364
Short-term operating lease liabilities 243,323 245,369
Other accrued liabilities 498,453 615,347
Total current liabilities 1,686,041 1,869,618
Long-term debt 1,020,499 1,020,700
Postretirement medical benefits 49,117 51,439
Pension liability 154,127 155,218
Long-term employee related benefits 110,759 108,544
Long-term operating lease liabilities 953,626 969,482
Other long-term liabilities 53,993 59,407
Total liabilities 4,028,162 4,234,408
Commitments and contingencies
Levi Strauss & Co. stockholders’ equity    
Common stock — $0.001 par value; 1,200,000,000 Class A shares authorized, 98,906,606 shares and 97,567,627 shares issued and outstanding as of February 27, 2022 and November 28, 2021, respectively; and 422,000,000 Class B shares authorized, 299,610,904 shares and 302,209,813 shares issued and outstanding, as of February 27, 2022 and November 28, 2021, respectively 399 400
Additional paid-in capital 575,310 584,774
Accumulated other comprehensive loss (411,374) (394,387)
Retained earnings 1,559,254 1,474,874
Total stockholders’ equity 1,723,589 1,665,661
Total liabilities and stockholders’ equity $ 5,751,751 $ 5,900,069